New and versatile syntheses of 3-alkyl- and 3-aryl-1,2,4-benzotriazine 1,4-dioxides: Preparation of the bioreductive cytotoxins SR 4895 and SR 4941

Tetrahedron Letters

Volumn 43, Issue 52, 2002, Pages 9569-9571

  Hay, Michael P ^a   Denny, William A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antitumour compounds; Benzotriazoles; Stille reaction; Suzuki reaction

Indexed keywords

1,2,4 BENZOTRIAZINE 1,4 DIOXIDE; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BENZENEBORONIC ACID; BORONIC ACID DERIVATIVE; CYTOTOXIN; OXIDE; PALLADIUM; SR 4895; SR 4941; TRIFLUOROPERACETIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL PROCEDURES; CHEMICAL REACTION; DRUG SYNTHESIS; OXIDATION; REDUCTION; SUZUKI REACTION;

EID: 0037164618     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(02)02417-6     Document Type: Article

References (31)

1. Brown J.M., Siim B.G. Semin. Radiat. Oncol. 6:1966;22-36
2. Denny, W. A.; Wilson, W. R.; Hay, M. P. Br. J. Cancer 1996, 74 (Suppl. XXVII), 32-38.
3. Straford I.J., Workman P. Anti-Cancer Drug Des. 13:1998;519-528.
4. Denny W.A., Wilson W.R. Exp. Opin. Invest. Drugs. 9:2000;2889-2901.
5. Walton M.I., Workman P. Biochem. Pharmacol. 39:1990;1735-1742.
6. Walton M.I., Wolf C.R., Workman P. Biochem. Pharmacol. 44:1992;251-259.
7. Patterson A.V., Barham H.M., Chinje E.C., Adams G.E., Harris A.L., Stratford I.J. Br. J. Cancer. 72:1995;1144-1150.
8. Patterson A.V., Saunders M.P., Chinje E.C., Patterson L.H., Stratford I.J. Anti-Cancer Drug Des. 13:1998;541-573.
9. Fitzsimmons S.A., Lewis A.D., Riley R.J., Workman P. Carcinogenesis. 15:1994;1503-1510.
10. Priyadarsini K.I., Tracy M., Wardman P. Free Rad. Res. 25:1996;393-399.
11. Laderoute K., Wardman P., Rauth A.M. Biochem. Pharmacol. 37:1988;1487-1495.
12. Jones G.D., Weinfeld M. Cancer Res. 56:1996;1584-1590.
13. Daniels J.S., Gates K.S., Tronche C., Greenberg M.M. Chem. Res. Toxicol. 11:1998;1254-1257.
14. Hwang J.T., Greenberg M.M., Fuchs T., Gates K.S. Biochemistry. 38:1999;14248-14255.
15. Ban F., Gauld J.W., Russel R.J. J. Am. Chem. Soc. 123:2001;7320-7325.
16. Dorie M.J., Kovacs M.S., Gabalski E.C., Adam M., Le Q.T., Bloch D.A., Pinto H.A., Terris D.J., Brown J.M. Neoplasia. 1:1999;461-467.
17. Brizel D.M., Dodge R.K., Clough R.W., Dewhirst M.W. Radiother. Oncol. 53:1999;113-117.
18. Kelson A.B., McNamara J.P., Pandey A., Ryan K.J., Dorie M.J., McAfee P.A., Menke D.R., Brown J.M., Tracy M. Anti-Cancer Drug Des. 13:1998;575-592.
19. Abramovitch R.A., Schofield K. J. Chem. Soc. 1955;2326-2336.
20. McNamara, J. P.; Kelson, A. B.; Ryan, K. J.; Yasuda, D. M.; Tosto, L. M.; Menke, D. R.; Brown, J. M.; Tracy, M. Abstract II-23, 8th International Conference on Chemical Modifiers of Cancer Treatment, Kyoto, Japan, June 16, 1993.
21. Stille J.K. Angew. Chem., Int. Ed. Engl. 25:1986;508-523.
22. Stille J.K., Groh B.L. J. Am. Chem. Soc. 109:1987;813-817.
23. Miyaura N., Suzuki A. Chem. Rev. 95:1995;2457-2483.
24. Li J.J., Gribble G.W. Palladium in Heterocyclic Chemistry: A Guide for the Synthetic Chemist. 2000;4-18 Pergamon, Amsterdam.
25. Mason J.C., Tennant G. J. Chem. Soc. (B). 1970;911-916.
26. Robbins R.F., Schofield K. J. Chem. Soc. 1957;3186-3194.
27. 2: C, 56.5; H, 4.7; N, 22.0. Found: C, 56.7; H, 4.6; N, 22.2%.
28. 3O: C, 64.2; H, 4.9; N, 22.5. Found: C, 63.9; H, 4.9; N, 22.7%.
29. Aoyama T., Shioiri T. Tetrahedron Lett. 31:1990;5507-5508.
30. 3: C, 54.3; H, 5.0; N, 19.0. Found: C, 54.1; H, 5.2; N, 19.0%.
31. 2: C, 66.4; H, 4.4; N, 16.6. Found: C, 66.5; H, 4.4; N, 16.7%.